Real-world outcomes of newly diagnosed multiple myeloma patients treated with front-line daratumumab bortezomib lenalidomide and dexamethasone
- PMID: 41784017
- DOI: 10.3324/haematol.2025.300401
Real-world outcomes of newly diagnosed multiple myeloma patients treated with front-line daratumumab bortezomib lenalidomide and dexamethasone
Abstract
Not available.
LinkOut - more resources
Full Text Sources
